BioSpace News Archive

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV), an advanced medical technologies company, today announced that two clinical case studies demonstrating the clinical effectiveness of ColActive® Plus and ColActive® Transfer biological matrix products will be presented at the 2018 Symposium on Advanced Wound Care Spring

World PI Week is an international movement to bring together patients, families and health care professionals to raise awareness, and improve diagnosis and treatment of Primary Immunodeficiency (PI). www.worldpiweek.org

From the shortest time scales known in science, to the development of tomorrow’s computing architectures, the Frontiers in Optics + Laser Science APS/DLS (FIO + LS) plenary presentations will detail recent achievements in nanoscale computing and ultrafast laser applications.

ELLKAY, LLC announced today that Shreya Patel, ELLKAY Vice President of Product Management and Strategy, and Philippe Flamant, ELLKAY Vice President of Client Services, will be speaking at the 23rd annual Executive War College Conference on Laboratory & Pathology Management to be held May 1-2, 2018 in New Orleans.

International Biophysics Corporation announced two new patents have been issued from the United States Patent and Trademark Office (USPTO) for the company’s AffloVest® High Frequency Chest Wall Oscillation (HFCWO) vest.

Leading rare disease patient advocacy organizations Global Genes - Allies in Rare Disease and the EveryLife Foundation for Rare Diseases are pleased to announce the 2nd annual RARE on the Road - Rare Disease Leadership Tour.

Moviegoers can experience the heart-wrenching story of three-time world champion surfer Andy Irons when “Andy Irons: Kissed by God” comes to U.S. movie theaters this spring.

IRB Services has changed its name to Advarra.

Alliance Physical Therapy Partners has hired Richard Leaver as the Company’s new Chief Operating Officer.

Led by Capital Group Private Markets Active response received from a number of global professional investors